Zargis Medical Corp. licensed Stethographics Inc.’s lung sounds analysis technology for its telemedicine platform.
The Stamford, Conn.-based Speedus Corp. (NSDQ:SPDE) subsidiary inked an exclusive license agreement for Stethographics’ Food & Drug Administration-approved lung auscultation tool. Stethographics is a Boston-based developer of automated, noninvasive sound analysis products.
Zargis plans to incorporate the technology, which identifies clinically significant respiratory sounds, into its telemedicine and computer-aided auscultation platform. The company said the deal will allow it to expand into the respiratory sounds market.
Stethographics’ technology visually displays lung sounds in a way that’s similar to Zargis’ cardioscan heart murmur detection software, according to a press release. Stethographics was founded in 1998 by Dr. Raymond Murphy, a Tufts University School of Medicine professor.